Opening of the Summit: The Edge of Possible: Pushing Boundaries. Inspiring hope. Together.
Speaker:
Inger-Margrethe Stavdal Paulsen, Chair of the Norwegian Osteogenesis Imperfecta Association
Moderator:
Line Fris Frederiksen, Science Journalist
Rare Talks: Facing Global Uncertainties and Pushing boundaries for the future – What’s Next for Rare?
Speakers:
Katri Asikainen, President of HARSO Finland
Virginie Bros-Facer, Chief Executive Officer at EURORDIS-Rare Diseases Europe
Natasha Azzopardi Muscat, Director of the Division of Country Health Policies and Systems at the World Health Organization (WHO)
Moderator:
Hannah Kuchler, Global Pharmaceuticals Editor at the Financial Times
Patient empowerment – Highlights from the Patient Empowerment Survey
Speakers:
Anette Remme, Senior advisor in The Norwegian Federation of Organisations of Persons with Disabilities (FFO)
Sanna Leppäjoki-Tiistola, BBA, BEng – Volunteer patient advocacy from HARSO, Finland
Stephanie Juran, Project manager at Rare Diseases Sweden
Dana Vigier, Vice President Central Europe and Northen Europe Area Head Rare Disease Unit, Alexion AstraZeneca Rare Disease
Ida Steinlein, DEBRA Norway Chair and DEBRA International Youth Council Leader
Lena Lövqvist, Program Officer at the National Board of Health and Welfare in Sweden
Moderator:
Gudrun Helga Hardardottir, Einstok börn
Breakout sessions
Early Diagnosis:Olve Moldestad (Oslo University), Oskar Ahlberg (Swedish MPS Association), Dana Vigier (Alexion AstraZeneca Rare Disease), Moderator: Dr. Petra Wilson, Senior Advisor at FTI Consulting
Breakout sessions
Access & Health Data:Tenna Toft Sylvest (XLH), Anja Schiel (Norwegian Medicines Agency), Alexander Natz (EUCOPE), Marianne Silkjær Nielsen (CompCure), Ida Sofie Jensen (Lif), Malene Fischer (NUHA), Moderator: Rasmus Gjesing (WHO)
Breakout sessions
Implementation of National Strategies:Stein Are Aksnes (National Center for Rare Diagnoses, Norway), Lena Lövqvist (National Board of Health and Welfare), Vigdís Fjóla Stefánsdóttir (Landspítali), Gabriella Almberg (UCB), Daniel Scherman (CNRS) Moderator: Katri Asikainen (HARSO),
Keynote Speech by the Minister for the Interior and Health of Denmark
Speaker:
Sophie Løhde, Minister for the Interior and Health of Denmark
HM Queen Mary will attend in her capacity as Patron for Rare Diseases Denmark.
Innovation in Rare: Can the Nordics become the Frontrunner? Can Europe Close the Gap?
Speakers:
Virginie Bros-Facer, CEO at EURORDIS
Stine Bosse, Member of the European Parliament, Renew
Malene Fischer, Nordic University Hospital Alliance
Jean-Luc Delay, President Europe & Canada at Takeda
Anna Wedell, Professor/Senior Physician, Karolinska Institutet
Moderator:
Dr. Petra Wilson, Senior Advisor at FTI Consulting
Pushing the Boundaries in Science: What Can the Nordics Teach Us on the Value of Genomics Sequencing?
Speakers:
Gudjón Reykdal Oskarsson, Researcher at Decode
Sven-Eric Söder, General Director at Swedish National Council on Medical Ethics
Hans Tómas Björnsson, Chief of Department, Department of Genetics and Molecular Medicine, Landspitali. Professor at University of Iceland, Associate Professor at Johns Hopkins University
Troels Rasmussen, Senior Advisor at Danish National Genome Center
Moderator:
Dr. Petra Wilson, Senior Advisor at FTI Consulting
Breakout Sessions
Early Diagnosis:Olve Moldestad (Oslo University), Oskar Ahlberg (Swedish MPS Association), Dana Vigier (Alexion AstraZeneca Rare Disease), Moderator: Dr. Petra Wilson, Senior Advisor at FTI Consulting
Implementation of National Strategies:Stein Are Aksnes (National Center for Rare Diagnoses, Norway), Lena Lövqvist (National Board of Health and Welfare, Sweden), Vigdís Fjóla Stefánsdóttir (Landspítali), Gabriella Almberg (UCB), Daniel Scherman (CNRS), Moderator: Katri Asikainen (HARSO)
Closing remarks: Handing over Hope: Passing the baton of Rare Disease recommendations to the Nordic Council of Ministers and the Next EU Presidency
Speakers:
Liselotte Wesley Andersen, Patient Representative at SBONN
Cypriot Presidency Representative*
Muriel De Vos, Corporate Vice President, Global Medical Affairs Rare Disease at Novo Nordisk
Virginie Bros-Facer, Chief Executive Officer at EURORDIS-Rare Diseases Europe
Stine Bosse, Member of the European Parliament, Renew